Viewing Study NCT03407859

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-01-27 @ 10:23 AM
Study NCT ID: NCT03407859
Status: RECRUITING
Last Update Posted: 2024-03-15
First Post: 2017-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL
Sponsor: Zhujiang Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Therapy Related Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD19-CART View
None CD20-CART View
None CD10-CART View
None CD22-CART View
None Relapsed/Refractory B-ALL View
None MRD View
None CD70-CART View